A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity
Running, not enrolling · Phase 1 · Has a placebo group
Conditions studied: Obesity, Overweight
In brief
The study is testing a new study medicine to treat people living with overweight or obesity. The aim of this study is to see if the medicine is safe, how it works in your body, and what your body does to the study medicine. Participants will either get the study medicine or placebo (a "dummy medicine" similar to the study medicine but without active ingredients) given as an injection under your skin. Which treatment the participants get is decided by chance. The study medicine is a potential new medicine which cannot be prescribed by doctors.
Key facts
- Study ID
- NCT06577766
- Run by
- Novo Nordisk A/S
- People needed
- 63
- Starts
- 2024-09-03
- Expected to finish
- 2026-09-24
- Last updated by the study team
- 2026-03-17
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.
Where it is running
- ICON — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.